biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > so i guess the company was paying prophetofabsurdity?

<< Previous

Bullboard Posts

Next >>

Post by zwerp2000on Jan 23, 2023 1:11pm

156 Views

Post# 35240145

so i guess the company was paying prophetofabsurdity?

he tried relentlessly to sell this mtp deal to the 1 or 2 shareholders still on this board and now that the deal has been cancelled, he disappears. i always said he had no credibility so i thank him for proving me right

<< Previous

Bullboard Posts

Next >>

Full Circle Lithium goes global with its battery fire-fighter